Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

In today’s column we peruse a few of the most bloated pensions in the state hackerama. Every year, the state’s billion-dollar ...

The drug, developed by Genentech ... of transgenic goats (Capra aegagrus hircus), GTC Biotherapeutics of Framingham, Massachusetts, finally secured US approval for Atryn as well, from CBER.

State Rep. Priscila Sousa said there’s “tremendous” apprehension in Framingham because ICE is moving differently than it did ...

A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...

The Boston textbook publisher has acquired Visible Body, which specializes in making digital biomedical images for ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex Pharmaceuticals. The drug, which is called suzetrigine and will be sold under ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Several free classes at Richland Academy of the Arts are available for adults 60 and older. Early registration is recommended ...

Dating and relationships while in recovery from addiction are possible by taking the right approach. Prioritize your recovery ...

Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.